ST. LOUIS, Oct. 19, 2010 (GLOBE NEWSWIRE) -- Murphy Analytics (MA) has initiated coverage on True 2 Beauty Inc. (Pink Sheets:TRTB), a California based manufacturer and distributor of sexual enhancement pills and liquids. The Initiation Report contains a detailed discussion of TRTB business operations, market opportunity and competition, macroeconomic data and indicators, and risks. The Initiation Report is available at .
Analyst Patrick J. Murphy, CFA notes in the report: "The acquisition of Libigrow by TRTB was announced on 10/4/10 and the Company has begun the process of illustrating the market opportunity and detailing its operating and marketing strategies. Like many of the products sold by GNC, Vitamin Shoppe and others, the Food and Drug Administration has not evaluated the statements made by Libigrow with regard to its products, and the products are not intended to diagnose, treat, cure, or prevent, any disease. However, as evidenced by the success of Enzyte, GNC, Vitamin Shoppe and others, it seems to be clear that consumers continue to demand dietary supplement type products in general, with significant growth appearing to be likely to continue. The opportunity before TRTB, utilizing an effective marketing and business development plan, is to build upon the Company's success to date by delivering more product through existing channels and developing a robust distribution network."
About Murphy Analytics
Murphy Analytics is an independent investment research firm providing coverage of microcap and smallcap stocks. Utilizing institutional caliber, fundamental, bottom-up analysis, Murphy Analytics helps investors make informed investment decisions about equities without extensive analyst coverage, with a focus on small-cap and micro-cap public stocks. Murphy Analytics LLC is owned by Patrick J. Murphy, who has over 15 years of capital markets experience, providing institutional investment and transaction analysis across a range of asset classes including microcap equities, commercial real estate debt and equity, municipal derivatives and public finance, venture capital, fixed income, CMBS and mortgage REIT's.
Disclosure: Murphy Analytics (MA) was compensated $8,500 in advance of the publication of this report. Neither MA nor the analyst owns or trades the shares of covered companies. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. MA provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. This report is neither a solicitation to buy nor an offer to sell securities and is to be used for informational purposes only and should not be used as basis for investment decisions. MA is not an investment advisor or broker/dealer and this report does not provide investment advice.
CONTACT: Murphy Analytics Patrick J. Murphy, CFA 636-273-9440 pmurphy@murphyanalytics.com